Legend Biotech was founded in 2014 as an early-stage cell therapy company by visionary scientists with expertise in immunology and gene editing. Initially known as the “Legend Project,” they began in a space as small as a freight elevator, with the goal of developing groundbreaking treatments for multiple myeloma.
Over the years, the company shifted its focus to pioneering CAR-T cell therapies, becoming one of the first to engineer CAR-T cells targeting the BCMA protein. Today, Legend Biotech is a global, commercial-stage leader in cell therapy, continuously expanding its pipeline of innovative platforms.
For more details, visit Legend Biotech.
The visit is on Friday, March 21 at 13:00 and the meeting place is at Technologiepark-Zwijnaarde 116, 9052 Gent (AA Tower). Places are limited, so be sure to secure your spot!
Please remember to bring your ID with you.
Please note: If you have already secured a ticket for the trip, you automatically have access to the Legend Biotech company visit.